ViewRay Announces Primary Endpoint Outcome from First Prospective, Multi-Institutional Study to Deliver Ablative Doses of Radiation to Pancreatic Cancer Patients
Study's primary objective of low grade 3+ toxicity was met; exploration of secondary outcomes underway to confirm local control rates and patient outcomes with MRIdian SMART
DENVER, Oct. 24, 2022 -- (Healthcare Sales & Marketing Network) -- ViewRay, In... Devices, Oncology ViewRay, MRIdian, MRI-guided radiation therapy, MRIdian A3i (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 24, 2022 Category: Pharmaceuticals Source Type: news
ASTRO: Physicists add value in patient-facing role
Radiation therapy patients report less anxiety when a medical physicist explain...Read more on AuntMinnie.comRelated Reading:
Don't modify the quench button: MRI safety grabs attention at ISMRM
Patients lack knowledge on radiation in medical imaging
Assigning dedicated MRI safety roles can reduce risk
No shield from x-rays: How science is rethinking lead aprons
Can radiation therapy and cremation safely coexist? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 24, 2022 Category: Radiology Source Type: news
Local Therapy Extends Use of Targeted Drugs in Oligoprogressive Lung Cancer
(MedPage Today) -- Patients with advanced, mutated lung cancer had "clinically meaningful" continuation of treatment beyond progression following local therapy, primarily radiation therapy (RT), a small retrospective analysis showed.
The median... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 21, 2022 Category: Hematology Source Type: news
UCLA researchers identify gene as potential target in treatment-resistant brain cancer
Doctors and scientists at UCLA Jonsson Comprehensive Cancer Center and the UCLA Jane and Terry Semel Institute for Neuroscience and Human Behavior have identified a gene that may provide a therapeutic target for the deadly, treatment-resistant brain cancer glioblastoma multiforme.The gene, P300, enables cancer cells that have been damaged by radiation therapy to recover by rearranging DNA and initiating a molecular mechanism that refortifies tumor cells for growth and survival.In studies using mice and in human glioblastoma multiforme cells, the scientists discovered that blocking P300 disrupted its ability to set ...
Source: UCLA Newsroom: Health Sciences - October 20, 2022 Category: Universities & Medical Training Source Type: news
ART to offer AccuBoost technology to China
Radiation therapy firm Advanced Radiation Therapy (ART) entered into a technolog...Read more on AuntMinnie.comRelated Reading:
ART brings AccuBoost breast irradiation system to Jordan
VA Ann Arbor expands use of ViewRay radiation therapy
ART debuts ConfidenceRT breast brachytherapy system
Advanced Radiation Therapy names new CCO
ART installs breast system in Fla. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 14, 2022 Category: Radiology Source Type: news
CMS to reimburse for automated CCTA procedures
The U.S. Centers for Medicare and Medicaid Services (CMS) has assigned a ne...Read more on AuntMinnie.comRelated Reading:
CMS officially postpones changes to radiation therapy payments
Imaging groups push back against proposed 2023 Medicare cuts
Midyear radiology coding update and other reminders
What's in store for radiology in the 2023 Medicare Proposed Rule?
CMS releases proposed Medicare Physician Fee Schedule for 2023 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 13, 2022 Category: Radiology Source Type: news
PET/CT scans predict low thyroid function in radiotherapy patients
Early post-treatment PET/CT scans in patients undergoing radiotherapy for hea...Read more on AuntMinnie.comRelated Reading:
Dual-tracer PET/CT shows promise in cancer imaging
CT finds secondary lung disease in head and neck cancer survivors
Second-look PET/CT catches cancer spread
PET/CT shows promise predicting outcomes in head, neck cancer
Can 3D-printed shields protect patients during radiation therapy? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 13, 2022 Category: Radiology Source Type: news
GT Medical Technologies Announces First Patient Enrolled in GESTALT Trial of GammaTile(R) Therapy for Newly Diagnosed Glioblastoma Brain Tumors
This phase 4 clinical trial evaluates the use of GammaTile Therapy at the time of surgery combined with the standard Stupp protocol for patients with newly diagnosed glioblastomas.
TEMPE, Ariz., Oct. 11, 2022 -- (Healthcare Sales & Marketing Network) -... Devices, Oncology, Neurosurgery GT Medical Technologies, GammaTile, Surgically Targeted Radiation Therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 11, 2022 Category: Pharmaceuticals Source Type: news
AI delivers clinical decision support and workflow improvements
Artificial intelligence (AI)-based applications are having a significant impac...Read more on AuntMinnie.comRelated Reading:
IMV: Broad use of fixed C-arms in hospitals drives future demand
Nuclear medicine sentiment improves with expectations for higher volume
IMV: Radiation therapy capital equipment budgets up 21% in 2021
IMV: Most U.S. hospitals plan to buy an x-ray system
IMV: MRI procedure volume fell 35% in 2020 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 7, 2022 Category: Radiology Source Type: news
Image-Guided Superficial Radiation as First-line in Skin Cancer? Image-Guided Superficial Radiation as First-line in Skin Cancer?
For non-melanoma skin cancer, image-guided superficial radiation therapy offered comparable disease control to Mohs surgery. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 30, 2022 Category: Dermatology Tags: Hematology-Oncology News Source Type: news
Accuray Announces First CyberKnife(R) Systems in Africa, Providing a New Option and Hope for Potentially Life-Saving Radiation Treatments for More Cancer Patients
World's Only Robotic Radiation Therapy Device Delivers Extremely Precise Treatments in Just 1 to 5 Out-Patient Sessions
SUNNYVALE, Calif., Sept. 30, 2022 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced today t... Devices, Oncology Accuray, CyberKnife, radiotherapy, stereotactic radiosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 30, 2022 Category: Pharmaceuticals Source Type: news
Varian adds Australia's Icon Group to HyperArc registry
Siemens Healthineers radiation therapy unit Varian has added Australia's Ico...Read more on AuntMinnie.comRelated Reading:
Varian secures IDE for new Flash clinical trial
Siemens Healthineers Q2 numbers driven by diagnostics, Varian
Varian earns IMV 2021 ServiceTrak awards
Varian completes enrollment in clinical trial of Flash rad therapy
Varian highlights new offerings at ASTRO 2021 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 26, 2022 Category: Radiology Source Type: news
Hermes Medical donates AI software to Regis College
Sweden's Hermes Medical Solutions has donated molecular imaging artificial intelligenc...Read more on AuntMinnie.comRelated Reading:
Hermes, Isotopia sign deal on dosimetry
Hermes lands FDA clearance for Affinity
Hermes gets FDA clearance for radiation dose software
Hermes launches new radiation therapy software
Hermes appoints new president, CEO (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 23, 2022 Category: Radiology Source Type: news
MD Anderson Cancer Center Selects ViewRay to Expand MR-Guided Radiation Therapy Program
First MRIdian system to be installed at MD Anderson main campus at the Texas Medical Center in Houston
DENVER, Sept. 20, 2022 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the University of Texas MD Ande... Devices, Oncology ViewRay, MRIdian, MRI-guided radiation therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 20, 2022 Category: Pharmaceuticals Source Type: news
ASTRO applauds legislation on 'real-time' prior authorizations
The American Society for Radiation Oncology (ASTRO) is applauding passage o...Read more on AuntMinnie.comRelated Reading:
ASTRO issues guide on radiation therapy for glioma
CMS officially postpones changes to radiation therapy payments
Biden administration confirms Bertagnolli to lead NCI
ASTRO recognizes fellows class for 2022
ASTRO sees opportunity in CMS delay of RO Model (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 15, 2022 Category: Radiology Source Type: news
